Russia's Biocad Awaits Approval of Drug Based on 2018 Nobel Prize Research

MOSCOW (Sputnik) - Russian biotechnology company Biocad expects its cancer medicine that is based on research by 2018 Nobel laureates to be approved in the second quarter of next year, the Biocad president told Sputnik in an interview.

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

Sputnik [+]    Biocad [+]    Nobel [+]   

More #news: